These are the most popular UK shares to buy right now, but are they actually good investments, or traps leading investors ...

CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...

The move will be a boost for Donald Trump's incoming administration. But it will be seen as a setback for the Labour Government.

For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated ...